<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 09, 2023</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05613855</url>
  </required_header>
  <id_info>
    <org_study_id>performance score outcome</org_study_id>
    <nct_id>NCT05613855</nct_id>
  </id_info>
  <brief_title>Performance of Pulmonary Embolism Risk Scores Out Come in CTPA Confirmed Patients</brief_title>
  <official_title>Performance of Pulmonary Embolism Risk Scores for Assessment of Outcome in Computed Tomographic Pulmonary Angiography Confirmed Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assiut University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Assiut University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      1. Assess performance of PERFORM score in predicting outcome in CTPA confirmed patients.&#xD;
&#xD;
        2. Compare PERFORM score with the currently validated PESI in risk stratification of&#xD;
           patients&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Pulmonary embolism (PE) is a common and potentially lethal condition in the emergency&#xD;
      department requiring early and accurate management.&#xD;
&#xD;
      The short-term mortality rate of PE varies widely and ranges from less than 2% in many&#xD;
      patients with non massive PE to more than 95% in patients who experience cardiorespiratory&#xD;
      arrest.&#xD;
&#xD;
      Although several prognostic models of acute PE are currently used, all of them have practical&#xD;
      limitations.&#xD;
&#xD;
      Of all clinical scores integrating PE severity and comorbidity, the Pulmonary Embolism&#xD;
      Severity Index (PESI) and its simplified version,(sPESI) have been most extensively validated&#xD;
      to date.&#xD;
&#xD;
      However, current prognostic scores for pulmonary embolism (PE) are partly based on patients&#xD;
      without PE confirmation via computed tomographic pulmonary angiography (CTPA), involving&#xD;
      subjective parameters and complicated scoring methods [8].&#xD;
&#xD;
      Therefore, an objective, accurate, and simple prognostic model in CTPA-confirmed patients to&#xD;
      predict the risk of 30-day mortality. help clinicians assess patients' risks and improve&#xD;
      therapeutic decision-making that is called PERFORM score (pulmonary embolism risk score for&#xD;
      mortality)&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">November 2022</start_date>
  <completion_date type="Anticipated">April 2024</completion_date>
  <primary_completion_date type="Anticipated">April 2024</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Assess performance of PERFORM score in predicting outcome in CTPA confirmed patients.</measure>
    <time_frame>from 11/2022 to 4/2024</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Compare PERFORM score with the currently validated PESI in risk stratification of patients.</measure>
    <time_frame>from 11/2022 to 4/2024</time_frame>
  </secondary_outcome>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Pulmonary Embolism</condition>
  <eligibility>
    <study_pop>
      <textblock>
        The study will be on patients wh are above 18 years okd who are daignosed to have pulmonary&#xD;
        embolism with CTPA&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        - Patients above 18 years old with PE confirmed by CTPA are considered for inclusion in the&#xD;
        study.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  â€¢ Patients who have contraindications for CTPA eg. Renal impairment&#xD;
&#xD;
               -  Patients diagnosed and treated as PE without doing CTPA.&#xD;
&#xD;
               -  Patients who refuse to participate in the study&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
  </eligibility>
  <overall_contact>
    <last_name>Nourhan Safwat Abdelraheem, resiedent doctor</last_name>
    <phone>01067885766</phone>
    <email>nourhansafwat22@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Suzan Salama Sayed, professor</last_name>
    <phone>01014236163</phone>
    <email>suzan.ahmed@med.au.edu.eg</email>
  </overall_contact_backup>
  <results_reference>
    <citation>Anderson FA Jr, Wheeler HB, Goldberg RJ, Hosmer DW, Patwardhan NA, Jovanovic B, Forcier A, Dalen JE. A population-based perspective of the hospital incidence and case-fatality rates of deep vein thrombosis and pulmonary embolism. The Worcester DVT Study. Arch Intern Med. 1991 May;151(5):933-8.</citation>
    <PMID>2025141</PMID>
  </results_reference>
  <results_reference>
    <citation>Kurkciyan I, Meron G, Sterz F, Janata K, Domanovits H, Holzer M, Berzlanovich A, Bankl HC, Laggner AN. Pulmonary embolism as a cause of cardiac arrest: presentation and outcome. Arch Intern Med. 2000 May 22;160(10):1529-35. doi: 10.1001/archinte.160.10.1529.</citation>
    <PMID>10826469</PMID>
  </results_reference>
  <results_reference>
    <citation>Jimenez D, Aujesky D, Moores L, Gomez V, Lobo JL, Uresandi F, Otero R, Monreal M, Muriel A, Yusen RD; RIETE Investigators. Simplification of the pulmonary embolism severity index for prognostication in patients with acute symptomatic pulmonary embolism. Arch Intern Med. 2010 Aug 9;170(15):1383-9. doi: 10.1001/archinternmed.2010.199.</citation>
    <PMID>20696966</PMID>
  </results_reference>
  <results_reference>
    <citation>Elias A, Mallett S, Daoud-Elias M, Poggi JN, Clarke M. Prognostic models in acute pulmonary embolism: a systematic review and meta-analysis. BMJ Open. 2016 Apr 29;6(4):e010324. doi: 10.1136/bmjopen-2015-010324.</citation>
    <PMID>27130162</PMID>
  </results_reference>
  <results_reference>
    <citation>Agnelli G, Becattini C. Acute pulmonary embolism. N Engl J Med. 2010 Jul 15;363(3):266-74. doi: 10.1056/NEJMra0907731. Epub 2010 Jun 30. No abstract available.</citation>
    <PMID>20592294</PMID>
  </results_reference>
  <results_reference>
    <citation>Yu S, Zhou H, Li Y, Song J, Shao J, Wang X, Xie Z, Qiu C, Sun K. PERFORM: Pulmonary embolism risk score for mortality in computed tomographic pulmonary angiography-confirmed patients. EClinicalMedicine. 2021 May 31;36:100897. doi: 10.1016/j.eclinm.2021.100897. eCollection 2021 Jun.</citation>
    <PMID>34136775</PMID>
  </results_reference>
  <verification_date>November 2022</verification_date>
  <study_first_submitted>November 7, 2022</study_first_submitted>
  <study_first_submitted_qc>November 7, 2022</study_first_submitted_qc>
  <study_first_posted type="Actual">November 14, 2022</study_first_posted>
  <last_update_submitted>November 7, 2022</last_update_submitted>
  <last_update_submitted_qc>November 7, 2022</last_update_submitted_qc>
  <last_update_posted type="Actual">November 14, 2022</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Assiut University</investigator_affiliation>
    <investigator_full_name>Nourhan Safwat Abdelraheem Hussien</investigator_full_name>
    <investigator_title>Resident doctor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pulmonary Embolism</mesh_term>
    <mesh_term>Embolism</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

